跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72 条关于
“UKMHRA”
全部
72
临床试验
1
药物
0
机构
0
资讯
71
去年
Marksans Pharma Subsidiary Receives UK Marketing Authorization for Metformin Oral Solution
去年
Marksans Pharma Subsidiary Receives FDA Establishment Inspection Report Following New York Facility Review
2年前
MHRA Approves Sanofi/Regeneron's Dupixent for Uncontrolled COPD
去年
Fruquintinib Approved in Japan for Previously Treated Metastatic Colorectal Cancer
去年
Alnylam's Zilebesiran Receives MHRA Innovation Passport for Hypertension Treatment
去年
Erdafitinib Approved in the UK for Bladder Cancer with FGFR3 Alterations
去年
Pheno Therapeutics' PTD802 Receives MHRA Approval for MS Clinical Trial
去年
MHRA Launches Public Consultation for Personalized mRNA Cancer Vaccine Regulations
去年
Johnson & Johnson's Balversa Receives MHRA Approval for Bladder Cancer Treatment
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
第 1 页,共 8 页
上一页
下一页